Sister organization George Medicines, a late-stage drug development company focused on providing innovative and accessible medicines for the world’s leading causes of death, announced the appointment of Stefan König as Chief Executive Officer. George Medicines, a venture-backed spin-out company from The George Institute for Global Health, one of the world’s leading independent medical research institutes, […]
Read MoreSYDNEY, June 15, 2021 – George Clinical, a global scientifically-backed clinical research organization, and Omico, an Australian-based not-for-profit national precision oncology platform, have aligned to revolutionize oncology clinical trial access for patients and improve the efficiency of study enrollment. The two organizations began collaborating in late 2020 and announced the joint effort during the 2021 […]
Read More
The important achievements of clinical research around the world hold the potential to improve the health and wellness of humanity. Both leading projects day to day as well going the extra mile behind the scenes stand more than 300 of our dedicated, professional project team members across 38 geographical locations throughout the USA, Asia-Pacific region and […]
Read MoreDetailed results from the primary analysis of the DARE-19 Phase III trial assessing the potential of Farxiga (dapagliflozin), a sodium-glucose cotransporter 2 (SGLT2) inhibitor, to treat patients hospitalized with COVID-19 who are at risk of developing serious complications showed that the trial did not achieve statistical significance for the two primary endpoints. However, there were […]
Read MoreBEIJING and SYDNEY, April 29, 2021 – Guangzhou Link Health Pharma Co., Ltd. (Link Health) and George Clinical Pty Ltd (George Clinical) have signed a term sheet to enter into a strategic agreement to establish an independent joint venture clinical development company called Link-George Clinical Research Co., Ltd (Link-George). Link-George will deliver clinical trials for […]
Read More
When clinical trials become a normal part of care options for patients with unmet needs, both researchers and patients will reap exponential rewards. “Where are the patients?” Clinical trials hinge on recruitment, and enrollment issues are a perpetual challenge. Research estimates that, on average, around 20-25% of trials across all phases and therapeutic areas are […]
Read More
Dr. Adrian Liew, a nephrologist and scientific leader with George Clinical, was the recipient of the 2020 International Society for Peritoneal Dialysis Congress John Maher Award, honoring young individuals who have contributed substantially to the field of peritoneal dialysis (PD). Maher was a great contributor to the advancement of hemodialysis and peritoneal dialysis. He directed […]
Read MoreOVERLAND PARK, Ks., February 23, 2021 – David Hunter, MBBS, PhD, a renowned clinical researcher and rheumatology expert based in Australia, has joined the scientific leadership of George Clinical, a global scientifically-backed clinical research organization. Professor Hunter’s research focus is clinical and translational research in osteoarthritis (OA). He is the Florance and Cope Chair of […]
Read MoreThe COVID-19 pandemic continues to bring challenges to all of us on personal and professional levels but the importance of clinical research has perhaps never been higher. Our priority at George Clinical continues to be the safety and wellbeing of our employees, patients, investigators, clients and partners as we continue to execute critical studies in […]
Read More“Extraordinary achievements under unprecedented conditions,” is how Chief Medical Officer Maria Ali describes the reality of a George Clinical team drawing on proven working models, established global relationships and an unflinching dedication to implement a clinical trial in a matter of weeks during a global pandemic. Getting the job done despite extreme conditions The […]
Read More
